Peroxisome biogenesis disorders.

Defects in PEX genes impair peroxisome assembly and multiple metabolic pathways confined to this organelle, thus providing the biochemical and molecular bases of the peroxisome biogenesis disorders (PBD). PBD are divided into two types--Zellweger syndrome spectrum (ZSS) and rhizomelic chondrodysplasia punctata (RCDP). Biochemical studies performed in blood and urine are used to screen for the PBD. DNA testing is possible for all of the disorders, but is more challenging for the ZSS since 12 PEX genes are known to be associated with this spectrum of PBD. In contrast, PBD-RCDP is associated with defects in the PEX7 gene alone. Studies of the cellular and molecular defects in PBD patients have contributed significantly to our understanding of the role of each PEX gene in peroxisome assembly.

[1]  H. Moser,et al.  Plasma and Red Blood Cell Fatty Acids in Peroxisomal Disorders , 1999, Neurochemical Research.

[2]  R. Wanders,et al.  Alkyl dihydroxyacetone phosphate synthase in human fibroblasts and its deficiency in Zellweger syndrome. , 1985, Journal of lipid research.

[3]  R. Wanders,et al.  Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. , 1999, Human molecular genetics.

[4]  J. Ulrich,et al.  Adrenoleukodystrophy. Preliminary report of a connatal case. Light- and electron microscopical, immunohistochemical and biochemical findings. , 1978, Acta neuropathologica.

[5]  R. Wanders,et al.  A novel aberrant splicing mutation of the PEX16 gene in two patients with Zellweger syndrome. , 2002, Biochemical and biophysical research communications.

[6]  P. Lazarow,et al.  Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence , 1996, The Journal of cell biology.

[7]  H. Moser,et al.  Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. , 2003, American journal of human genetics.

[8]  R. Wanders,et al.  PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders. , 1999, American journal of human genetics.

[9]  H. Waterham,et al.  Peroxisome biogenesis disorders with prolonged survival: Phenotypic expression in a cohort of 31 patients , 2004, American journal of medical genetics. Part A.

[10]  H. Moser,et al.  Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata , 1997, Nature Genetics.

[11]  R. Wanders,et al.  Activity of peroxisomal enzymes and intracellular distribution of catalase in Zellweger syndrome. , 1984, Biochemical and biophysical research communications.

[12]  H. Moser,et al.  Striated adrenocortical cells in cerebro-hepato-renal (Zellweger) syndrome , 2004, Virchows Archiv A.

[13]  H. Waterham,et al.  Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder , 2004, European Journal of Human Genetics.

[14]  S. Gould,et al.  Pex12 Interacts with Pex5 and Pex10 and Acts Downstream of Receptor Docking in Peroxisomal Matrix Protein Import , 1999, The Journal of cell biology.

[15]  S. Tamura,et al.  The pathogenic peroxin Pex26p recruits the Pex1p–Pex6p AAA ATPase complexes to peroxisomes , 2003, Nature Cell Biology.

[16]  H. Nittono,et al.  Oral bile Acid treatment in two Japanese patients with Zellweger syndrome. , 2002, Journal of pediatric gastroenterology and nutrition.

[17]  J. I. Pedersen,et al.  Peroxisomal dysfunction in a boy with neurologic symptoms and amaurosis (Leber disease): clinical and biochemical findings similar to those observed in Zellweger syndrome. , 1986, The Journal of pediatrics.

[18]  R. Wanders,et al.  Temperature-Sensitive Mutation of PEX6 in Peroxisome Biogenesis Disorders in Complementation Group C (CG-C): Comparative Study of PEX6 and PEX1 , 2000, Pediatric Research.

[19]  Kirby D. Smith,et al.  Therapeutic developments in peroxisome biogenesis disorders , 2000, Expert opinion on investigational drugs.

[20]  D. Crane,et al.  Novel PEX1 coding mutations and 5′ UTR regulatory polymorphisms , 2005, Human mutation.

[21]  H. Moser,et al.  The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum. , 2004, Molecular genetics and metabolism.

[22]  A. Moser,et al.  Biochemical analysis of cultured chorionic villi for the prenatal diagnosis of peroxisomal disorders: biochemical thresholds and molecular sensitivity for maternal cell contamination detection , 2005, Journal of Medical Genetics.

[23]  S. Gould,et al.  Identification of a common PEX1 mutation in Zellweger syndrome , 1999, Human mutation.

[24]  R. Wanders,et al.  Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome. , 1984, Biochemical and biophysical research communications.

[25]  R. Wanders,et al.  Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Moser,et al.  Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. , 1999, Journal of lipid research.

[27]  P. Mayerhofer,et al.  Two splice variants of human PEX19 exhibit distinct functions in peroxisomal assembly. , 2002, Biochemical and biophysical research communications.

[28]  R. Wanders,et al.  Molecular mechanism of detectable catalase-containing particles, peroxisomes, in fibroblasts from a PEX2-defective patient. , 2000, Biochemical and biophysical research communications.

[29]  H. Moser,et al.  Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders , 1997, Nature Genetics.

[30]  H. Waterham,et al.  A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents. , 2002, American journal of human genetics.

[31]  D. Valle,et al.  Disorders of peroxisome biogenesis. , 1995, Human molecular genetics.

[32]  K. Ghaedi,et al.  PEX3 is the causal gene responsible for peroxisome membrane assembly-defective Zellweger syndrome of complementation group G. , 2000, American journal of human genetics.

[33]  D. Sillence,et al.  Ultrastructure and immunocytochemistry of hepatic peroxisomes in rhizomelic chondrodysplasia punctata , 1992, European Journal of Pediatrics.

[34]  H. Waterham,et al.  Novel Mutations in the PEX2 Gene of Four Unrelated Patients with a Peroxisome Biogenesis Disorder , 2004, Pediatric Research.

[35]  A. Moser,et al.  Orthotopic liver transplantation from a living-related donor in an infant with a peroxisome biogenesis defect of the infantile Refsum disease type , 2005, Journal of Inherited Metabolic Disease.

[36]  H. Moser,et al.  Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders , 1995, Nature Genetics.

[37]  H. Waterham,et al.  Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. , 2001, American journal of human genetics.

[38]  D. Johnson,et al.  Unique molecular species of phosphatidylcholine containing very-long-chain (C24-C38) polyenoic fatty acids in rat brain. , 1990, The Biochemical journal.

[39]  D. Platt,et al.  The biological significance of plasmalogens in defense against oxidative damage , 1998, Experimental Gerontology.

[40]  D. Crane,et al.  A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype , 1999, Human Genetics.

[41]  M. Noetzel.  Fish oil and myelin , 1998, Neurology.

[42]  M. Baumgartner,et al.  Mutations in antiquitin in individuals with pyridoxine-dependent seizures , 2006, Nature Medicine.

[43]  Y Fujiki,et al.  Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction. , 2001, The Biochemical journal.

[44]  Ann Moser,et al.  Mutations in the Peroxin Pex26p Responsible for Peroxisome Biogenesis Disorders of Complementation Group 8 Impair Its Stability, Peroxisomal Localization, and Interaction with the Pex1p·Pex6p Complex* , 2006, Journal of Biological Chemistry.

[45]  A. Das,et al.  Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents , 1992, Lipids.

[46]  S. Denis,et al.  Major hyperpipecolataemia in a normal adult , 1996, Journal of Inherited Metabolic Disease.

[47]  R. Pauli,et al.  Natural history of rhizomelic chondrodysplasia punctata , 2003, American journal of medical genetics. Part A.

[48]  P. K. Chakraborty,et al.  Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype , 2002, Human mutation.

[49]  W. Kearns,et al.  Preimplantation Genetic Diagnosis and Screening , 2005, Seminars in reproductive medicine.

[50]  H. Moser,et al.  PEX7 gene structure, alternative transcripts, and evidence for a founder haplotype for the frequent RCDP allele, L292ter. , 2000, Genomics.

[51]  V. Caviness,et al.  The mechanism of arrest of neuronal migration in the Zellweger malformation: An hypothesis based upon cytoarchitectonic analysis , 1978, Acta Neuropathologica.

[52]  Hugo Moser,et al.  Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. , 2006, Molecular genetics and metabolism.

[53]  A. Moser,et al.  Pharmacological induction of peroxisomes in peroxisome biogenesis disorders , 2000, Annals of neurology.

[54]  A. Moser,et al.  Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. , 1995, The Journal of pediatrics.

[55]  Terje Svingen,et al.  Novel PEX1 mutations and genotype–phenotype correlations in Australasian peroxisome biogenesis disorder patients , 2002, Human mutation.

[56]  W. Kleijer,et al.  Disturbed very long chain (C24–C26) fatty acid pattern in fibroblasts of patients with Zellweger's syndrome , 1985, Journal of Inherited Metabolic Disease.

[57]  S. Gould,et al.  Phenotype‐genotype relationships in PEX10‐deficient peroxisome biogenesis disorder patients , 2000 .

[58]  R. Wanders,et al.  Stability of Alkyl‐Dihydroxyacetonephosphate Synthase in Human Control and Peroxisomal Disorder Fibroblasts , 1999, IUBMB life.

[59]  H. Moser,et al.  Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders. , 1998, American journal of human genetics.

[60]  É. Vázquez,et al.  MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders , 1998, Neurology.

[61]  H. Moser,et al.  Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders , 1997, Nature Genetics.

[62]  H. Moser,et al.  The prenatal diagnosis of the cerebro‐hepato‐renal syndrome of Zellweger , 1985, Prenatal diagnosis.

[63]  M. Durán,et al.  MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata , 2006, Neurology.

[64]  T. Imanaka,et al.  Temperature-sensitive phenotypes of peroxisome-assembly processes represent the milder forms of human peroxisome-biogenesis disorders. , 1998, American journal of human genetics.

[65]  J. Gärtner,et al.  Genomic organization and characterization of human PEX2 encoding a 35-kDa peroxisomal membrane protein. , 2000, Biochemical and biophysical research communications.

[66]  M. D. Lloyd,et al.  Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation , 2002 .

[67]  A. Wierzbicki.  Clinical significance of oxidation from phytol to phytanic acid in man. , 2004, Molecular genetics and metabolism.

[68]  H. Moser,et al.  The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. , 1984, The New England journal of medicine.

[69]  K. Ghaedi,et al.  The Mammalian Peroxin Pex5pL, the Longer Isoform of the Mobile Peroxisome Targeting Signal (PTS) Type 1 Transporter, Translocates the Pex7p·PTS2 Protein Complex into Peroxisomes via Its Initial Docking Site, Pex14p* , 2000, The Journal of Biological Chemistry.

[70]  M. Haust,et al.  Hyperpipecolatemia: A new metabolic disorder associated with neuropathy and hepatomegaly: A case study. , 1968, Canadian Medical Association journal.

[71]  N. Shimozawa,et al.  Genetic heterogeneity of peroxisome biogenesis disorders among Japanese patients: Evidence for a founder haplotype for the most common PEX10 gene mutation , 2003, American journal of medical genetics. Part A.

[72]  D. Crane,et al.  Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects. , 1996, The Journal of clinical investigation.

[73]  R. Wanders,et al.  Identification of a new complementation group of the peroxisome biogenesis disorders and PEX14 as the mutated gene , 2004, Human mutation.

[74]  S. Ferdinandusse,et al.  Reinvestigation of trihydroxycholestanoic acidemia reveals a peroxisome biogenesis disorder , 2004, Neurology.

[75]  H. Moser,et al.  Fatty alcohol accumulation in the autosomal recessive form of rhizomelic chondrodysplasia punctata. , 1993, Biochemical medicine and metabolic biology.

[76]  J. Gärtner,et al.  Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations , 2005, Journal of Medical Genetics.

[77]  A. Moser,et al.  Biochemical abnormalities in rhizomelic chondrodysplasia punctata. , 1988, The Journal of pediatrics.

[78]  D. Crane,et al.  PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders , 2005, Human mutation.

[79]  J. Fryns,et al.  Prenatal ultrasound diagnosis of rhizomelic chondrodysplasia punctata in a primigravida , 1994, Prenatal diagnosis.

[80]  R. Wanders,et al.  A new type of peroxisomal disorder with variable expression in liver and fibroblasts. , 1994, The Journal of pediatrics.

[81]  P. Mayerhofer,et al.  Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G. , 2000, American journal of human genetics.

[82]  H. J. Brink,et al.  Rapid and quantitative analysis of unconjugated C(27) bile acids in plasma and blood samples by tandem mass spectrometry. , 2001, Journal of lipid research.

[83]  R. Wanders,et al.  PEX1 deficiency presenting as Leber congenital amaurosis. , 2004, Pediatric neurology.

[84]  N. Braverman,et al.  Cervical stenosis secondary to rhizomelic chondrodysplasia punctata. , 2001, American journal of medical genetics.

[85]  P. Borst,et al.  Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome) , 1983, Nature.

[86]  H. Waterham,et al.  Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40°C: Implications for other inborn errors of metabolism , 2004, Human mutation.

[87]  H. Moser,et al.  Increased very long chain fatty acids in patients on a ketogenic diet: a cause of diagnostic confusion. , 1993, The Journal of pediatrics.

[88]  M. Skoneczny,et al.  Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor , 1997, Nature Genetics.

[89]  D. Danks,et al.  Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. , 1975, The Journal of pediatrics.

[90]  H. Moser,et al.  Structural and Chemical Alterations in the Cerebral Maldevelopment of Fetal Cerebro‐Hepato-Renal (Zellweger) Syndrome , 1989, Journal of neuropathology and experimental neurology.

[91]  P. Beaune,et al.  Infantile phytanic acid storage disease, a possible variant of Refsum's disease: Three cases, including ultrastructural studies of the liver , 1982, Journal of Inherited Metabolic Disease.

[92]  I. Björkhem,et al.  Simple diagnosis of the Zellweger syndrome by gas-liquid chromatography of dimethylacetals. , 1986, Journal of lipid research.

[93]  T. Tsukamoto,et al.  A human gene responsible for Zellweger syndrome that affects peroxisome assembly. , 1992, Science.

[94]  R. Wanders,et al.  High incidence of hyperoxaluria in generalized peroxisomal disorders. , 2006, Molecular genetics and metabolism.

[95]  H. Moser,et al.  Genomic structure and identification of 11 novel mutations of the PEX6 (peroxisome assembly factor‐2) gene in patients with peroxisome biogenesis disorders , 1999, Human mutation.

[96]  M. Durán,et al.  Short Report: Plasma pipecolic acid is frequently elevated in non-peroxisomal disease , 2003, Journal of Inherited Metabolic Disease.

[97]  A. Beyer,et al.  Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders , 1997, Nature Genetics.

[98]  K. Setchell,et al.  Oral bile acid treatment and the patient with zellweger syndrome , 1992, Hepatology.

[99]  C. Chang,et al.  Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders. , 1998, American journal of human genetics.

[100]  H. Moser,et al.  Diagnosis and Follow-Up of a Case of Peroxisomal Disorder With Peroxisomal Mosaicism , 1999, Journal of child neurology.

[101]  H. Moser,et al.  Peroxisomal ghosts are intracellular structures distinct from lysosomal compartments in Zellweger Syndrome: A confocal laser scanning microscopy study , 2000, Biology of the cell.

[102]  P. Rehling,et al.  Domain Mapping of Human PEX5 Reveals Functional and Structural Similarities to Saccharomyces cerevisiae Pex18p and Pex21p* , 2001, The Journal of Biological Chemistry.

[103]  H. Tabak,et al.  Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. , 2002, American journal of human genetics.

[104]  H. Tabak,et al.  Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor , 1997, Nature Genetics.

[105]  D. Hansell,et al.  Skeletal abnormalities in Refsum's disease (heredopathia atactica polyneuritiformis). , 1990, The British journal of radiology.

[106]  R. Wanders,et al.  Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders , 2004, Clinical genetics.

[107]  S. Ferdinandusse,et al.  Peroxisomal fatty acid alpha- and beta-oxidation in health and disease: new insights. , 2003, Advances in experimental medicine and biology.

[108]  D. Johnson,et al.  The occurrence of polyenoic very long chain fatty acids with greater than 32 carbon atoms in molecular species of phosphatidylcholine in normal and peroxisome-deficient (Zellweger's syndrome) brain. , 1988, The Biochemical journal.

[109]  D. Valle,et al.  An isoform of pex5p, the human PTS1 receptor, is required for the import of PTS2 proteins into peroxisomes. , 1998, Human molecular genetics.

[110]  R. Wanders,et al.  UvA-DARE ( Digital Academic Repository ) Defective PEX gene products correlate with the protein import , biochemical abnormalities , and phenotypic heterogeneity in peroxisome biogenesis disorders , 1999 .

[111]  T. Tsukamoto,et al.  A novel mutation, R125X in peroxisome assembly factor‐1 responsible for zellweger syndrome , 1998, Human mutation.

[112]  R. G. Holmes,et al.  Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy. , 1986, American journal of medical genetics.

[113]  Y. Kuroki,et al.  Human peroxisome assembly factor-2 (PAF-2): a gene responsible for group C peroxisome biogenesis disorder in humans. , 1996, American journal of human genetics.

[114]  Jeremy M. Berg,et al.  Molecular dynamics simulations of biomolecules , 2002, Nature Structural Biology.

[115]  S. South,et al.  Peroxisome Synthesis in the Absence of Preexisting Peroxisomes , 1999, The Journal of cell biology.

[116]  F. Garzuly,et al.  [Cerebro-hepato-renal (Zellweger) syndrome]. , 1974, Orvosi hetilap.

[117]  C. Obie,et al.  Alternative splicing suggests extended function of PEX26 in peroxisome biogenesis. , 2005, American journal of human genetics.

[118]  J. Volpe,et al.  Cerebro-hepato-renal syndrome of Zellweger: An inherited disorder of neuronal migration , 2004, Acta Neuropathologica.

[119]  M. Baumgartner,et al.  Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffman disease , 1998, Neurology.

[120]  A. A. Spector,et al.  Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. , 1995, Journal of lipid research.

[121]  H. Waterham,et al.  UvA-DARE ( Digital Academic Repository ) Identification of PEX 7 as the second gene involved in Refsum disease , 2003 .

[122]  L. Horrocks,et al.  Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia , 2001 .

[123]  H. Moser,et al.  Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. , 1995, Journal of cell science.

[124]  Y. Suzuki,et al.  Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. , 1998, American journal of human genetics.

[125]  Y. Suzuki,et al.  Mutations in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. , 1998, Human molecular genetics.

[126]  H. Waterham,et al.  Biochemical markers predicting survival in peroxisome biogenesis disorders , 2002, Neurology.

[127]  I. Rapin,et al.  Peroxisomal and Mitochondrial Defects in the Cerebro-Hepato-Renal Syndrome , 1973, Science.

[128]  N. Boddaert,et al.  Contribution of fetal MR imaging in the prenatal diagnosis of Zellweger syndrome. , 2006, AJNR. American journal of neuroradiology.

[129]  T. Tsukamoto,et al.  PEX12, the Pathogenic Gene of Group III Zellweger Syndrome: cDNA Cloning by Functional Complementation on a CHO Cell Mutant, Patient Analysis, and Characterization of Pex12p , 1998, Molecular and Cellular Biology.

[130]  E. Jellum,et al.  Epoxy acids in peroxisomal disorders. , 1986, Scandinavian journal of clinical and laboratory investigation.

[131]  H. Bernheimer,et al.  The Cerebrohepatorenal (Zellweger) Syndrome: An Improved Method for the Biochemical Diagnosis and its Potential Value for Prenatal Detection , 1985, Pediatric Research.

[132]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.